{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:24:54Z","timestamp":1775244294053,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1115107"],"award-info":[{"award-number":["1115107"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R01HD070888-01A1"],"award-info":[{"award-number":["1R01HD070888-01A1"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA046794"],"award-info":[{"award-number":["R01DA046794"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addiction Neuroscience"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.addicn.2023.100127","type":"journal-article","created":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T19:20:03Z","timestamp":1693077603000},"page":"100127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Chronic oral methylphenidate plus fluoxetine treatment in adolescent rats increases cocaine self-administration"],"prefix":"10.1016","volume":"8","author":[{"given":"Daniela","family":"Senior","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Xuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hadjiargyrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayotis K.","family":"Thanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0001","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1592\/phco.26.10.1501","article-title":"Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration","volume":"26","author":"Teter","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.addicn.2023.100127_bib0002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003-2011","volume":"53","author":"Visser","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"4","key":"10.1016\/j.addicn.2023.100127_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.8707","article-title":"Prescription stimulant medical and nonmedical use among US secondary school students, 2005 to 2020","volume":"6","author":"McCabe","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0004","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2010.127","article-title":"Very early predictors of adolescent depression and suicide attempts in children with attention-deficit\/hyperactivity disorder","volume":"67","author":"Chronis-Tuscano","year":"2010","journal-title":"Arch. Gen. Psychiatry"},{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0005","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1007\/s12035-021-02466-y","article-title":"Fluoxetine potentiates oral methylphenidate-induced gene regulation in the rat striatum","volume":"58","author":"Moon","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.addicn.2023.100127_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-016-0716-x","article-title":"Psychotropic drug use among 0\u201317 year olds during 2004\u20132014: a nationwide prescription database study","volume":"16","author":"Hartz","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"0 1","key":"10.1016\/j.addicn.2023.100127_bib0007","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neuropharm.2004.06.021","article-title":"Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules","volume":"1","author":"Carlezon","year":"2004","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.addicn.2023.100127_bib0008","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.biopsych.2004.10.037","article-title":"Early developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats","volume":"57","author":"Mague","year":"2005","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.addicn.2023.100127_bib0009","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1016\/j.neubiorev.2011.02.011","article-title":"Neurobehavioral adaptations to methylphenidate: the issue of early adolescent exposure","volume":"35","author":"Marco","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0010","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","article-title":"Antidepressants and body weight: a comprehensive review and meta-analysis","volume":"71","author":"Serretti","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.addicn.2023.100127_bib0011","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pneurobio.2012.10.001","article-title":"Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants","volume":"100","author":"Steiner","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.addicn.2023.100127_bib0012","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.biopsych.2009.10.004","article-title":"Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers?","volume":"67","author":"Steiner","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.addicn.2023.100127_bib0013","series-title":"Fluoxetine: Pharmacology, Mechanisms of Action and Potential Side Effects","first-page":"207","article-title":"Fluoxetine and other SSRI antidepressants potentiate addiction-related gene regulation by psychostimulant medications","author":"VanWaes","year":"2015"},{"key":"10.1016\/j.addicn.2023.100127_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neuropharm.2014.08.024","article-title":"Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor","volume":"89","author":"Van Waes","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.addicn.2023.100127_bib0015","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pbb.2015.01.005","article-title":"A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior","volume":"131","author":"Thanos","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1-2","key":"10.1016\/j.addicn.2023.100127_bib0016","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s002210050545","article-title":"Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior","volume":"123","author":"Steiner","year":"1998","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.addicn.2023.100127_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2014.02.021","article-title":"Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration","volume":"82","author":"Calipari","year":"2014","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.addicn.2023.100127_bib0018","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tips.2007.10.004","article-title":"Methylphenidate and cocaine: the same effects on gene regulation?","volume":"28","author":"Yano","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.addicn.2023.100127_bib0019","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neubiorev.2003.11.001","article-title":"Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs","volume":"27","author":"Vezina","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.addicn.2023.100127_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.addbeh.2010.08.010","article-title":"Structural, concurrent, and predictive validity of the Substance Use Risk Profile Scale in early adolescence","volume":"36","author":"Krank","year":"2011","journal-title":"Addict. Behav."},{"issue":"4","key":"10.1016\/j.addicn.2023.100127_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/jpm13040574","article-title":"Behavioral, neurochemical and developmental effects of chronic oral methylphenidate: a review","volume":"13","author":"Senior","year":"2023","journal-title":"J Pers Med"},{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0022","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2174\/1389201024666221028092342","article-title":"Combined chronic oral methylphenidate and fluoxetine treatment during adolescence: effects on behavior","volume":"24","author":"Thanos","year":"2023","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.addicn.2023.100127_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pbb.2018.07.001","article-title":"Recovery from behavior and developmental effects of chronic oral methylphenidate following an abstinence period","volume":"172","author":"Martin","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.addicn.2023.100127_bib0024","article-title":"Selective serotonin re-uptake inhibitors (SSRIS) induced weight changes: a dose and duration dependent study on albino rats","volume":"10","author":"Aggarwal","year":"2016","journal-title":"J. Clin. Diagn. Res. JCDR"},{"issue":"4","key":"10.1016\/j.addicn.2023.100127_bib0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pbb.2007.05.020","article-title":"Effects of chronic oral methylphenidate on cocaine self-administration and striatal dopamine D2 receptors in rodents","volume":"87","author":"Thanos","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"23","key":"10.1016\/j.addicn.2023.100127_bib0026","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1523\/JNEUROSCI.1244-10.2010","article-title":"Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking","volume":"30","author":"Knackstedt","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.addicn.2023.100127_bib0027","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbr.2018.08.014","article-title":"Weekday-only chronic oral methylphenidate self-administration in male rats: Reversibility of the behavioral and physiological effects","volume":"356","author":"Carias","year":"2019","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.addicn.2023.100127_bib0028","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1542\/peds.98.4.763","article-title":"Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication","volume":"98","author":"Schertz","year":"1996","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.addicn.2023.100127_bib0029","doi-asserted-by":"crossref","DOI":"10.1186\/1687-9856-2012-30","article-title":"Weight loss on stimulant medication: how does it affect body composition and bone metabolism? - A prospective longitudinal study","volume":"2012","author":"Poulton","year":"2012","journal-title":"Int. J. Pediatr. Endocrinol."},{"issue":"2","key":"10.1016\/j.addicn.2023.100127_bib0030","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.resp.2013.02.020","article-title":"Fluoxetine augments ventilatory CO2 sensitivity in brown norway but not sprague dawley rats","volume":"186","author":"Hodges","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"2","key":"10.1016\/j.addicn.2023.100127_bib0031","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2014-3421","article-title":"Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis","volume":"100","author":"Domecq","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.addicn.2023.100127_bib0032","series-title":"Combined Chronic Oral Methylphenidate and Fluoxetine Treatment During Adolescence: Effects on Behavior","author":"Thanos","year":"2022"},{"issue":"1","key":"10.1016\/j.addicn.2023.100127_bib0033","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00213-010-2011-8","article-title":"Early methylphenidate exposure enhances cocaine self-administration but not cocaine-induced conditioned place preference in young adult rats","volume":"213","author":"Crawford","year":"2011","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.addicn.2023.100127_bib0034","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0893-133X(01)00281-0","article-title":"Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats","volume":"25","author":"Brandon","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.addicn.2023.100127_bib0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-3057(02)00735-9","article-title":"Pretreatment with methylphenidate sensitizes rats to the reinforcing effects of cocaine","volume":"72","author":"Schenk","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.addicn.2023.100127_bib0036","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00213-018-5096-0","article-title":"Juvenile exposure to methylphenidate and guanfacine in rats: effects on early delay discounting and later cocaine-taking behavior","volume":"236","author":"Freund","year":"2019","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.addicn.2023.100127_bib0037","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/syn.10038","article-title":"Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications","volume":"43","author":"Volkow","year":"2002","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.addicn.2023.100127_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.baga.2014.10.001","article-title":"Potentiated gene regulation by methylphenidate plus fluoxetine treatment: Long-term gene blunting (Zif268, Homer1a) and behavioral correlates","volume":"4","author":"Beverley","year":"2014","journal-title":"Basal Ganglia"},{"issue":"6","key":"10.1016\/j.addicn.2023.100127_bib0039","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/adb.12067","article-title":"Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a","volume":"19","author":"Van Waes","year":"2014","journal-title":"Addict. Biol."},{"issue":"2","key":"10.1016\/j.addicn.2023.100127_bib0040","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pharmthera.2007.06.011","article-title":"Dynorphin and the pathophysiology of drug addiction","volume":"116","author":"Shippenberg","year":"2007","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0041","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1007\/s12035-021-02466-y","article-title":"Fluoxetine potentiates oral methylphenidate-induced gene regulation in the rat striatum","volume":"58","author":"Moon","year":"2021","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.addicn.2023.100127_bib0042","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/add.14190","article-title":"Denise Kandel's classic work on the gateway sequence of drug acquisition: Kandel's gateway theory of drug use","volume":"113","author":"Lynskey","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.addicn.2023.100127_bib0043","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pmedr.2016.05.003","article-title":"Gateway hypothesis\" and early drug use: Additional findings from tracking a population-based sample of adolescents to adulthood","volume":"4","author":"Nkansah-Amankra","year":"2016","journal-title":"Prev. Med. Rep."},{"issue":"1-2","key":"10.1016\/j.addicn.2023.100127_bib0044","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.drugalcdep.2009.12.001","article-title":"Evaluating the drug use \"gateway\" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO world mental health surveys","volume":"108","author":"Degenhardt","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.addicn.2023.100127_bib0045","series-title":"The gateway Theory and Adolescent Substance Use","author":"Fredriksen","year":"2006"},{"issue":"12","key":"10.1016\/j.addicn.2023.100127_bib0046","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.addbeh.2014.07.009","article-title":"ADHD as a risk factor for early onset and heightened adult problem severity of illicit substance use: an accelerated gateway model","volume":"39","author":"Dunne","year":"2014","journal-title":"Addict. Behav."},{"key":"10.1016\/j.addicn.2023.100127_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117137","article-title":"Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?","volume":"418","author":"Gold","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.addicn.2023.100127_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyg.2014.00919","article-title":"Dopamine and glucose, obesity, and reward deficiency syndrome","volume":"5","author":"Blum","year":"2014","journal-title":"Front. Psychol."},{"issue":"5","key":"10.1016\/j.addicn.2023.100127_bib0049","first-page":"893","article-title":"Attention-deficit-hyperactivity disorder and reward deficiency syndrome","volume":"4","author":"Blum","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"5","key":"10.1016\/j.addicn.2023.100127_bib0050","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00702-017-1680-4","article-title":"Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats","volume":"124","author":"Robison","year":"2017","journal-title":"J. Neural Transm."},{"issue":"28","key":"10.1016\/j.addicn.2023.100127_bib0051","doi-asserted-by":"crossref","first-page":"10347","DOI":"10.1523\/JNEUROSCI.1470-11.2011","article-title":"Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood","volume":"31","author":"Warren","year":"2011","journal-title":"J. Neurosci."}],"container-title":["Addiction Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772392523000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772392523000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:13:20Z","timestamp":1757412800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772392523000706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":51,"alternative-id":["S2772392523000706"],"URL":"https:\/\/doi.org\/10.1016\/j.addicn.2023.100127","relation":{},"ISSN":["2772-3925"],"issn-type":[{"value":"2772-3925","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic oral methylphenidate plus fluoxetine treatment in adolescent rats increases cocaine self-administration","name":"articletitle","label":"Article Title"},{"value":"Addiction Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addicn.2023.100127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100127"}}